CN105683755B - 陷阱分子和检测分子的用途及其相关试剂盒和组合物 - Google Patents

陷阱分子和检测分子的用途及其相关试剂盒和组合物 Download PDF

Info

Publication number
CN105683755B
CN105683755B CN201480060361.3A CN201480060361A CN105683755B CN 105683755 B CN105683755 B CN 105683755B CN 201480060361 A CN201480060361 A CN 201480060361A CN 105683755 B CN105683755 B CN 105683755B
Authority
CN
China
Prior art keywords
analyte
binding molecule
trap
molecules
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480060361.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN105683755A (zh
Inventor
M.施雷姆尔
M.罗斯勒
M.盖格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN105683755A publication Critical patent/CN105683755A/zh
Application granted granted Critical
Publication of CN105683755B publication Critical patent/CN105683755B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201480060361.3A 2013-11-05 2014-11-03 陷阱分子和检测分子的用途及其相关试剂盒和组合物 Active CN105683755B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13005218.6 2013-11-05
EP13005218 2013-11-05
EP14002015.7 2014-06-11
EP14002015 2014-06-11
PCT/EP2014/073523 WO2015067547A1 (en) 2013-11-05 2014-11-03 A method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto

Publications (2)

Publication Number Publication Date
CN105683755A CN105683755A (zh) 2016-06-15
CN105683755B true CN105683755B (zh) 2019-08-13

Family

ID=51845410

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480060361.3A Active CN105683755B (zh) 2013-11-05 2014-11-03 陷阱分子和检测分子的用途及其相关试剂盒和组合物

Country Status (7)

Country Link
US (2) US10564151B2 (enExample)
EP (1) EP3066469B1 (enExample)
JP (1) JP6446044B2 (enExample)
CN (1) CN105683755B (enExample)
CA (1) CA2926306C (enExample)
ES (1) ES2654906T3 (enExample)
WO (1) WO2015067547A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108700576B (zh) * 2017-01-20 2021-07-02 深圳市新产业生物医学工程股份有限公司 制备抗体对的方法、试剂盒及试剂盒的应用和制备抗体对的系统
WO2024158727A2 (en) * 2023-01-24 2024-08-02 University Of Cincinnati Depletion-limited analyte sensing with non-equilibrium binding probes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE4214922C2 (de) 1992-05-06 1996-06-13 Brahms Diagnostica Gmbh Verfahren zur quantitativen Bestimmung des Anteils der freien Form eines Schilddrüsenhormon-Liganden in einer biologischen Flüssigkeit und Kit zur Durchführung eines solchen Verfahrens
US5312730A (en) * 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
AU4482896A (en) * 1995-01-31 1996-08-21 Novo Nordisk A/S A method of diagnosing preclinical diabetes
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
CN1867587A (zh) * 2003-08-14 2006-11-22 惠氏公司 抗Lewis Y抗独特型抗体及其用途
WO2005108989A2 (en) * 2004-04-16 2005-11-17 Genentech, Inc. Assay for antibodies
EP1861708A2 (en) * 2005-03-08 2007-12-05 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
CN101379399A (zh) 2005-12-22 2009-03-04 罗姆股份有限公司 免疫测定装置和方法
EP1801594A1 (en) * 2005-12-23 2007-06-27 Koninklijke Philips Electronics N.V. Sensing device and method for determination of the amount of target molecule in an analyte
US20080127359A1 (en) * 2006-11-06 2008-05-29 Hermann Beck Method for producing anti-idiotypic antibodies
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
EP2193145A4 (en) 2007-08-28 2011-05-18 Abbott Biotech Ltd COMPOSITIONS AND METHODS COMPRISING BINDING PROTEINS FOR ADALIMUMAB
FR2980271B1 (fr) * 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
BR112014011535A2 (pt) * 2011-12-19 2017-05-09 Hoffmann La Roche método para a determinação in vitro e imunológica de presença da presença e/ou da quantidade de um parceiro de ligação, método in vitro e utilização de um anticorpo
CN104105966B (zh) * 2012-02-01 2016-10-26 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的结合搭档的方法
WO2014009474A1 (en) * 2012-07-13 2014-01-16 F. Hoffmann-La Roche Ag Method for the detection of a multispecific binder
PE20160190A1 (es) * 2013-08-01 2016-04-28 Five Prime Therapeutics Inc Anticuerpos anti-fgfr2iiib afucosilados

Also Published As

Publication number Publication date
US12158466B2 (en) 2024-12-03
CN105683755A (zh) 2016-06-15
US20160252500A1 (en) 2016-09-01
US10564151B2 (en) 2020-02-18
US20200141930A1 (en) 2020-05-07
EP3066469B1 (en) 2017-10-11
ES2654906T3 (es) 2018-02-15
EP3066469A1 (en) 2016-09-14
JP2016535266A (ja) 2016-11-10
HK1225799A1 (zh) 2017-09-15
CA2926306C (en) 2022-12-06
JP6446044B2 (ja) 2018-12-26
CA2926306A1 (en) 2015-05-14
ES2654906T8 (es) 2018-02-26
WO2015067547A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
US11415576B2 (en) Method for measurement of vitamin D
CN106164672B (zh) 用于诊断的细胞表面前列腺癌抗原
CN105793709B (zh) 用于使用半抗原和结合所述半抗原的抗体作为参照抗体的免疫测量的方法，以及用于使用所述参照抗体的免疫测量的装置
US12158466B2 (en) Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
CN109336973B (zh) 抗转铁蛋白抗体及其用途
JP2020515286A5 (enExample)
TW202434888A (zh) 用於偵測及測定包括生物流體在內之流體中之蛋白質結構及穩定性的方法
JP2024534638A (ja) 薬物濃度及び標的濃度を定量化するためのアッセイ
EP3066122B1 (en) Pre-haptoglobin-2 monoclonal antibodies and uses thereof
HK1225799B (zh) 陷阱分子和检测分子的用途及其相关试剂盒和组合物
TWI869740B (zh) 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒
JP6407990B2 (ja) アウグリン免疫学的検定
WO2025232057A1 (zh) 可结合人cd137单克隆抗体或其功能性片段及其应用
CN108727493A (zh) 抗Stathmin单克隆抗体及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1225799

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant